Addiction Medicine Updates

Videos

UPDATES

OPIOIDS

SBIRT

TRAINING EVENTS

Latest News & Upcoming Events

Dr. Stephen Wyatt Receives Prestigious Glaser Award

Dr. Stephen Wyatt Receives Prestigious Glaser Award

RALEIGH, NC (April 2, 2019) – Stephen Wyatt, DO, medical director of Addiction Medicine at Atrium Health in Charlotte, was awarded the Frederick B. Glaser Award on March 23 at the Addiction Medicine 2019 conference held in Asheville, NC. The biennial award, given by...

10 Things to Know About Fentanyl

10 Things to Know About Fentanyl

In 2016, the powerful drug fentanyl claimed the life of music legend Prince and has, in recent years, largely contributed to the next wave of America’s opioid crisis. Here are 10 things you should know about fentanyl. 10 Things to Know About Fentanyl Learn more about...

Jan
29
Tue
Providers’ Clinical Support System – Buprenorphine Office Based Treatment for Opioid Use Disorders The “Half and Half” Course @ South East AHEC
Jan 29 @ 4:00 pm – 8:45 pm

Description

Opioid dependence is epidemic in the United States. While progress has been made in training providers, the gap in providing effective treatment of opioid use disorders continues to widen—moving beyond heroin addicted individuals to a much larger and diverse segment of the population. This increase is predominantly due to an alarming increase in addiction to prescription opioid analgesic medications. Buprenorphine, the most recent addition to the pharmacotherapies available to treat opioid dependence, is novel among the opioid pharmacotherapies because of its partial agonist properties. It has been placed on Schedule III and is available by prescription from a physician’s office-based practice.

Recognizing the impact of this addiction, as well as learning how to treat opioid use disorders, are important steps in combating this ever growing medical problem. To obtain the waiver to prescribe, providers are required to take specialized training. PCSS-MAT uses the Half-and-Half format (first, 4.25 hours of face-to-face training with an instructor, followed by 3.75 hours of on-your-own-training that must be completed along with a post test). This meets the training requirements for physicians; however, additional training is required for advanced practice providers. The training focuses on the specifics of treating patients with opioid use disorders in office-based settings and clinical vignettes to help trainees think through “real life” experiences in opioid use disorders treatment. Once the waiver training is completed in full, participants will receive a CME certificate of attendance from AAAP.

January 29, 2019, at SEAHEC, 2511 Delaney Ave., Seagull Classroom, Wilmington, NC 28403 Click here to register

HAVE A QUESTION?

Contact the Program Manager
Karen Lambert
karen.lambert@mahec.net or 828-257-4761

This course will also be offered at other locations:

February 5, 2019, at Greensboro AHEC, Moses H. Cone Memorial Hospital, 1121 North Church St., Classroom GW185 (formerly Classroom 29), Greensboro, NC 27401 Click here to register

By registering for this program, you are granting permission for your contact information to be shared with the North Carolina Medical Society Foundation, which is a collaborating partner of this continuing education activity.

Target Audience

The program is recommended for prescribers in primary care, emergency medicine, pain management, psychiatric, HIV, and addiction medicine.(Not a prescriber? CLICK HERE)

Objectives

  • Review addiction treatment in office-based practices
  • Discuss the pharmacological treatments of opioid use disorder
  • Determine what medical record documentation must be followed
  • Discuss the process of buprenorphine induction as well as stabilization and maintenance techniques
  • Describe how to take a patient history and evaluation
  • Review safety concerns and drug interactions
Feb
1
Fri
Treating Pain Safer: One Hour Online Course for Safe Opioid Prescribing – AVAILABLE NOW through March 15, 2021! @ Webinar
Feb 1 @ 12:00 am – 12:00 am

Treating Pain Safer: One Hour Online Course for Safe Opioid Prescribing

Description:
Literature has shown that prescribers receive little education on the treatment of pain resulting in less effective pain treatment with worse outcomes. Participants will learn the evidence-based analysis of the relative effectiveness of medications and their side effects, recommendations on how to improve treatment of acute and chronic pain and recognizing substance use/opioid use disorders. Participants in this online educational activity must pass a posttest for successful completion. This course will focus on acute pain treatments/prescribing that can decrease the likelihood of long-term use.

As of July 1, 2017 all physicians (other than residents), physician assistants, nurse practitioners, podiatrists, and dentists who prescribe controlled substances must satisfy the controlled-substance prescribing CE requirement as set forth by their NC professional boards. Requirements vary by discipline and board. Prescribers will turn in controlled substance CE credits when they renew licensure.

Course Objectives:
1. Describe the impact of the opioid crisis
2. Identify the CDC guidelines for prescribing opioids for acute pain and the STOP Act
3. Discuss opioid alternatives and office policies for safe opioid prescribing

Feb
5
Tue
Recovery Within Reach: Building Team Expertise in Office-Based Opioid Treatment (OBOT) – Greensboro AHEC @ Greensboro AHEC Moses H. Cone Memorial Hospital
Feb 5 @ 3:45 pm – 8:30 pm

Description

Opioid addiction is a chronic, relapsing brain disease that affects millions of Americans and produces a tremendous burden on the healthcare system. In 2002, U.S. physicians gained the opportunity to treat opioid-addicted patients with buprenorphine in primary care settings, commonly referred to as office-based opioid treatment (OBOT). OBOT has been shown to be effective in primary care settings and impacts public health through the reduction of opioid use, opioid overdose mortality and transmission of infectious diseases. However, it remains underutilized.

One consistently cited barrier preventing OBOT expansion is lack of adequate clinical support given the additional needs for patient monitoring. Successful medication-assisted treatment (MAT) requires a team-based approach just like treatment for other chronic diseases. In addition, treatment is more effective when providers can use a trauma-informed and gender-responsive treatment plan.

The goal of this companion program to the AAAP Clinical Support System: Buprenorphine Office-Based Treatment for Opioid Use Disorders (The “Half and Half” Course) is to increase the comfort level and expertise of the healthcare team by outlining a team approach, trauma-informed interventions, gender-responsive care, and recommendations for implementation of buprenorphine OBOT.

Target Audience

Recommended for mental health professionals (including substance abuse counselors, social workers, psychologists, school counselors, and marriage and family therapists), practice managers, program administrators, nurses, medical assistants, care managers, care coordinators and other professionals interested in this subject (Are you a prescriber? CLICK HERE)

Objectives

  • Describe the presented framework of office-based opioid treatment (OBOT) including practice changes, medications used, psychosocial services and integration/coordination components
  • Utilize evidence-based interventions that are trauma-informed and gender-responsive to treat persons with substance use disorders
  • Define the roles of an effective practice team, including primary care and behavioral health clinicians, working together with patients and families, and using a systematic and cost-effective approach to provide patient-centered care for opioid and other substance use disorders
  • Increase medical and behavioral health professionals’ receptivity and capability to work collaboratively as they evaluate and manage opioid and other substance use disorders using SBIRT (screening, brief intervention and referral to treatment)
  • List key components of evidence-based and effective OBOT

HAVE A QUESTION?

Contact the Program Manager
Karen Lambert
karen.lambert@mahec.net or 828-257-4761

By registering for this program, you are granting permission for your contact information to be shared with the North Carolina Medical Society Foundation, which is a collaborating partner of this continuing education activity.

Providers’ Clinical Support System – Buprenorphine Office Based Treatment for Opioid Use Disorders The “Half and Half” Course @ Greensboro AHEC Moses H. Cone Memorial Hospital
Feb 5 @ 4:00 pm – 8:45 pm

Description

Opioid dependence is epidemic in the United States. While progress has been made in training providers, the gap in providing effective treatment of opioid use disorders continues to widen—moving beyond heroin addicted individuals to a much larger and diverse segment of the population. This increase is predominantly due to an alarming increase in addiction to prescription opioid analgesic medications. Buprenorphine, the most recent addition to the pharmacotherapies available to treat opioid dependence, is novel among the opioid pharmacotherapies because of its partial agonist properties. It has been placed on Schedule III and is available by prescription from a physician’s office-based practice.

Recognizing the impact of this addiction, as well as learning how to treat opioid use disorders, are important steps in combating this ever growing medical problem. To obtain the waiver to prescribe, providers are required to take specialized training. PCSS-MAT uses the Half-and-Half format (first, 4.25 hours of face-to-face training with an instructor, followed by 3.75 hours of on-your-own-training that must be completed along with a post test). This meets the training requirements for physicians; however, additional training is required for advanced practice providers. The training focuses on the specifics of treating patients with opioid use disorders in office-based settings and clinical vignettes to help trainees think through “real life” experiences in opioid use disorders treatment. Once the waiver training is completed in full, participants will receive a CME certificate of attendance from AAAP.

February 5, 2019, at Greensboro AHEC, Moses H. Cone Memorial Hospital, 1121 North Church St., Classroom GW185 (formerly Classroom 29), Greensboro, NC 27401 Click here to register

HAVE A QUESTION?

Contact the Program Manager
Karen Lambert
karen.lambert@mahec.net or 828-257-4761

By registering for this program, you are granting permission for your contact information to be shared with the North Carolina Medical Society Foundation, which is a collaborating partner of this continuing education activity.

Target Audience

The program is recommended for prescribers in primary care, emergency medicine, pain management, psychiatric, HIV, and addiction medicine. Not a prescriber? CLICK HERE

Objectives

  • Review addiction treatment in office-based practices
  • Discuss the pharmacological treatments of opioid use disorder
  • Determine what medical record documentation must be followed
  • Discuss the process of buprenorphine induction as well as stabilization and maintenance techniques
  • Describe how to take a patient history and evaluation
  • Review safety concerns and drug interactions
Feb
8
Fri
Post-Overdose Response Team Regional Training in Kenansville, NC @ James Sprunt Community College (Duplin County)
Feb 8 all-day
Communities across the state are coming together to create an effective response to the significant increase in overdose deaths in recent years. Post-overdose response teams (PORTs) are an emerging strategy to meaningfully engage with people who have experienced overdose. These teams follow up with patients who have experienced an overdose within 72 hours. Teams seek to link the patient with appropriate care ranging from harm reduction services to treatment to recovery supports.
The NC Office of Emergency Medical Services in partnership with the NC Division of Public Health are hosting several regional trainings for post-overdose response team (PORT) development across the state. These PORT Trainings will equip participants to start or continue development of programs in partnership with first responders and harm reductionists. In addition to EMS-based partnerships, teams will learn to meaningfully engage with persons with lived experience or in recovery and other harm reduction specialists when developing and operating PORTs.
All first responders and public safety professionals are highly encouraged to attend the training. However, these trainings are open to anyone who is interested in developing a post-overdose response team in their community.
Program Objectives
  • Take a critical look at our understanding of substance use disorders, addiction science, and people who use drugs (PWUD).
  • Gain an understanding of more appropriate interventions, treatment, and linkage to care options for PWUD.
  • Examine what prevents people from seeking treatment.
  • Provide first responders and community partners with strategies aimed to identify resources in their community to support their team and how to make referrals to these agencies.
  • Equip you to develop a post-overdose response team to serve as a strategic approach to address overdose within your community.
Approximately 8 regional trainings for PORT development will be conducted across the state starting on the eastern side and through the western side over January to July 2019. The training will be one full business day (8a-5p). We are unable to provide travel support for attendance. Each training will cover the same information, so if you don’t see a training site in your area listed yet, please stay tuned for information on the upcoming trainings.
Feb
18
Mon
Treating Pain Safely: Fewer Opioids and Better Results Controlled Substances Education for Prescribers @ Swain County Hospital
Feb 18 @ 5:30 pm – 8:45 pm

Literature has shown that prescribers receive little education on the treatment of pain, resulting in less effective pain treatment with worse outcomes. Attendees will learn the evidence-based analysis of the relative effectiveness of medications and their side effects, recommendations on how to improve treatment of acute and chronic pain, and recognizing substance use/opioid use disorders. This program will include the three required topics outlined by the new CME requirement in 21 NCAC 32R .0101:

• Controlled substances prescribing practices
• Recognizing signs of the abuse or misuse of controlled substances
• Controlled substance prescribing for chronic pain management

As of July 1, 2017 all physicians (other than residents), physician assistants, nurse practitioners, podiatrists, and dentists who prescribe controlled substances must satisfy the controlled-substance prescribing CE requirements as set forth by their licensing boards; requirements vary by discipline and board. Physicians must follow the CME requirement per 21 NCAC 32R .0101 and will turn in record of controlled substance CME when they renew licensure.

Objectives

  • Describe the impact of the opioid crisis
  • Identify the CDC guidelines for prescribing opioids for acute pain
  • Identify the CDC guidelines for prescribing opioids for chronic pain
  • Discuss what to do with patients on opioids that fall outside the guidelines
Feb
26
Tue
Building Connections across Organizations: Working Together to Understand and Respond to the Opioid Epidemic in NC @ Gillings School of Global Public Health
Feb 26 @ 12:00 pm – 1:00 pm

The UNC Opioid Research Group presents:

Building Connections across Organizations: Working Together to Understand and Respond to the Opioid Epidemic in NC

 

Nidhi Sachdeva, MPH, Senior Research Program Leader

Department of Population Health Sciences at Duke University

 

February 26, 2019

12-1 pm

3005 Michael Hooker Research Center

Gillings School of Global Public Health

 

Lunch provided

Register by February 21

 

Need accommodations? Email Leah Taraskiewicz at leahkt@unc.edu

Mar
1
Fri
Treating Pain Safer: One Hour Online Course for Safe Opioid Prescribing – AVAILABLE NOW through March 15, 2021! @ Webinar
Mar 1 @ 12:00 am – 12:00 am

Treating Pain Safer: One Hour Online Course for Safe Opioid Prescribing

Description:
Literature has shown that prescribers receive little education on the treatment of pain resulting in less effective pain treatment with worse outcomes. Participants will learn the evidence-based analysis of the relative effectiveness of medications and their side effects, recommendations on how to improve treatment of acute and chronic pain and recognizing substance use/opioid use disorders. Participants in this online educational activity must pass a posttest for successful completion. This course will focus on acute pain treatments/prescribing that can decrease the likelihood of long-term use.

As of July 1, 2017 all physicians (other than residents), physician assistants, nurse practitioners, podiatrists, and dentists who prescribe controlled substances must satisfy the controlled-substance prescribing CE requirement as set forth by their NC professional boards. Requirements vary by discipline and board. Prescribers will turn in controlled substance CE credits when they renew licensure.

Course Objectives:
1. Describe the impact of the opioid crisis
2. Identify the CDC guidelines for prescribing opioids for acute pain and the STOP Act
3. Discuss opioid alternatives and office policies for safe opioid prescribing

Opioid Epidemic 2019: Promising Developments in Policy and Treatment @ University of North Carolina School of Social Work Auditorium
Mar 1 @ 9:00 am – 12:00 pm

This free workshop will feature presentations from physicians, pharmacists and social workers utilizing treatment models and influencing policies to make a difference in the lives of individuals and families impacted by the opioid epidemic. 

When:

March 1st, 2019
8:30: Registration and light breakfast
9:00-12:00 – Program

Where:

University of North Carolina School of Social Work Auditorium
325 Pittsboro Street, Chapel Hill, NC 27599 Directions

Workshop Fee:

Attendance is free

Registration: 

Once you login, please fill out all fields below, select the programs you would like to attend, and proceed to checkout. You must complete the checkout process for your registration to be complete and saved in our system.

**More information and live-streaming instructions will be sent via email at least 2 days prior to the workshop**

Continuing education:

5-7 business days after the program, you will be receiving an email that prompts you to login to your account at https://ssw.unc.edu/sswevents/  where you can fill out an evaluation and then print your personalized certificate.

 

Mar
21
Thu
Addiction Medicine Conference in Asheville, NC @ Renaissance Asheville Hotel
Mar 21 – Mar 23 all-day
Apr
1
Mon
Treating Pain Safer: One Hour Online Course for Safe Opioid Prescribing – AVAILABLE NOW through March 15, 2021! @ Webinar
Apr 1 @ 12:00 am – 12:00 am

Treating Pain Safer: One Hour Online Course for Safe Opioid Prescribing

Description:
Literature has shown that prescribers receive little education on the treatment of pain resulting in less effective pain treatment with worse outcomes. Participants will learn the evidence-based analysis of the relative effectiveness of medications and their side effects, recommendations on how to improve treatment of acute and chronic pain and recognizing substance use/opioid use disorders. Participants in this online educational activity must pass a posttest for successful completion. This course will focus on acute pain treatments/prescribing that can decrease the likelihood of long-term use.

As of July 1, 2017 all physicians (other than residents), physician assistants, nurse practitioners, podiatrists, and dentists who prescribe controlled substances must satisfy the controlled-substance prescribing CE requirement as set forth by their NC professional boards. Requirements vary by discipline and board. Prescribers will turn in controlled substance CE credits when they renew licensure.

Course Objectives:
1. Describe the impact of the opioid crisis
2. Identify the CDC guidelines for prescribing opioids for acute pain and the STOP Act
3. Discuss opioid alternatives and office policies for safe opioid prescribing

Apr
4
Thu
Treating Pain Safely: Fewer Opioids and Better Results Controlled Substances Education for Prescribers @ MAHEC Mary C. Nesbitt Biltmore Campus, Pisgah Room
Apr 4 @ 5:30 pm – 8:45 pm

Literature has shown that prescribers receive little education on the treatment of pain, resulting in less effective pain treatment with worse outcomes. Attendees will learn the evidence-based analysis of the relative effectiveness of medications and their side effects, recommendations on how to improve treatment of acute and chronic pain, and recognizing substance use/opioid use disorders. This program will include the three required topics outlined by the new CME requirement in 21 NCAC 32R .0101:

• Controlled substances prescribing practices
• Recognizing signs of the abuse or misuse of controlled substances
• Controlled substance prescribing for chronic pain management

As of July 1, 2017 all physicians (other than residents), physician assistants, nurse practitioners, podiatrists, and dentists who prescribe controlled substances must satisfy the controlled-substance prescribing CE requirements as set forth by their licensing boards; requirements vary by discipline and board. Physicians must follow the CME requirement per 21 NCAC 32R .0101 and will turn in record of controlled substance CME when they renew licensure.

Objectives

  • Describe the impact of the opioid crisis
  • Identify the CDC guidelines for prescribing opioids for acute pain
  • Identify the CDC guidelines for prescribing opioids for chronic pain
  • Discuss what to do with patients on opioids that fall outside the guidelines
Apr
7
Sun
Opioid Use Disorder Course during the NC OBGYN Society Annual Meeting @ Raleigh Marriott Crabtree Valley Hotel
Apr 7 @ 7:00 am – 12:30 pm

The ASAM Treatment of Opioid Use Disorder Course covers the highest quality, evidence- based practices for treating patients
with opioid use disorder. The combined online enduring material and live activity will provide the required 8 hours needed to
obtain the waiver to prescribe buprenorphine in office-based treatment of opioid use disorder. The curriculum for this course
has been specifically designed for women’s health providers.

The ASAM Treatment of Opioid Use Disorder Course is designed for:
• Physicians, nurse practitioners, physician assistants, and clinical nurse specialists who wish to obtain a waiver to prescribe buprenorphine in office-based treatment of opioid use disorder.
• Clinicians and healthcare team members working with providers who prescribe buprenorphine in office-based treatment of opioid use disorder.

Learning Objectives:
• Assess patients for the full spectrum of harmful opioid use including misuse and use disorders.
• Describe procedures for initiating, stabilizing, maintaining, monitoring and modifying treatment of patients on buprenorphine or naltrexone.
• Describe unique issues of treating adolescents, young adults, pregnant and postpartum patients maintained on medications for opioid use disorder.
• Apply for a waiver to prescribe buprenorphine to patients with opioid use disorder.

Schedule (in conjunction with 4-hour online course):

7:55am-12:30pm Treatment of Opioid Use Disorder Course (Nathan Mullins, MD)
9:30am-10:00am Break / Networking
12:30pm Adjourn

ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training.

ACCME ACCREDITATION STATEMENT: The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT: The American Society of Addiction Medicine designates this enduring material for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The American Society of Addiction Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DATA 2000 training provided through the UNC Extension for Community Health Care Outcomes for Rural Primary Care Medication Assisted Treatment (UNC ECHO for MAT) is made possible by funding from the Agency for Healthcare Research and Quality (AHRQ) Grant number: 1R18HSO25065-01.

Apr
13
Sat
Waiver Training Online PCSS Office-Based Treatment for Opioid Use Disorders Webinar @ Live Webcast
Apr 13 @ 8:00 am – 12:15 pm

As of the requirements to obtain the waiver, physicians without specified experience must complete not less than 8 hours of training. A total of 8 hours of training is federally mandated for physicians and a total of 24 hours of training is mandated for NPs and PAs.

The first half of the training is a 4.25-hour live webcast. The second half of the course is a 3.75-hour computer-based study.An examination on the computer study must be successfully completed within 30 days of the webinar session as part of the process to obtain a waiver for prescribing buprenorphine. 

Instructions on how to log on to the second half of the course will be provided via email, ONLY to those who complete the 4.25-hour live webcast in its entirety. Please note that in order to be eligible for the waiver to prescribe Buprenorphine, you must complete a total of 8 hours consisting of the live webcast session (4.25-hours) and the online self-study session and exam (3.75-hours) within 30 days of the live webcast session. The AOAAM cannot verify completion of the webinar session if less than 4.25 hours are attended. Should you not attend for the entire session, you will have to retake the entire webinar again on a different date in order to get credit. Please be aware that it is MANDATORY that you are able to view and hear the presentation and participate in the interactive polling questions in order for the AOAAM to verify your attendance. The combined live webcast and online self-study training will provide the required 8 hours needed to obtain the waiver to prescribe buprenorphine in office-based treatment of opioid dependence. Physicians who complete this course will meet the training qualification under the new law. For NPs and PAs, an additional 16-hours of training will be required for waiver eligibility.

CONTINUING MEDICAL EDUCATION: This program has been approved for 4.25 AOA Category 1-A CME credits (live webcast session only) providing all requirements have been met. It has also been approved for 4.25 AAFP Prescribed Credit hours, which are eligible for the AMA’s Physician Recognition Award Credit. Participants are required to attend the entire 4.25-hour session, participate in the interactive polling questions and complete the post-test with a passing grade of 70% in order to be eligible for CME credit. CME certificates will become available once all components of the training are fulfilled.

For More Information and FREE training and educational resources on Medication Assisted Treatment –Providers’ Clinical Support System for Medication Assisted Treatment (PCSS-MAT) visit www.pcssnow.org.

PCSS is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in partnership with the: American Osteopathic Academy of Addiction Medicine (AOAAM); Addiction Technology Transfer Center (ATTC); American Academy of Family Physicians (AAFP); American Academy of Neurology (AAN); American Academy of Pain Medicine (AAPM); American Academy of Pediatrics (AAP); American College of Emergency Physicians (ACEP); American College of Physicians (ACP); American Dental Association (ADA); American Medical Association (AMA); American Psychiatric Association (APA); American Psychiatric Nurses Association (APNA); American Society of Addiction Medicine (ASAM); American Society for Pain Management Nursing (ASPMN); Association for Medical Education and Research in Substance Abuse (AMERSA); International Nurses Society on Addictions (IntNSA); National Association of Community Health Centers (NACHC); National Association of Drug Court Professionals (NADCP), and the Southeast Consortium for Substance Abuse Training (SECSAT). 

Funding for this initiative was made possible (in part) by grant nos. 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Apr
22
Mon
Waiver Training Online PCSS Office-Based Treatment for Opioid Use Disorders Webinar @ Live Webcast
Apr 22 @ 5:00 pm – 9:15 pm

As of the requirements to obtain the waiver, physicians without specified experience must complete not less than 8 hours of training. A total of 8 hours of training is federally mandated for physicians and a total of 24 hours of training is mandated for NPs and PAs.

The first half of the training is a 4.25-hour live webcast. The second half of the course is a 3.75-hour computer-based study. An examination on the computer study must be successfully completed within 30 days of the webinar session as part of the process to obtain a waiver for prescribing buprenorphine. 

Instructions on how to log on to the second half of the course will be provided via email, ONLY to those who complete the 4.25-hour live webcast in its entirety. Please note that in order to be eligible for the waiver to prescribe Buprenorphine, you must complete a total of 8 hours consisting of the live webcast session (4.25-hours) and the online self-study session and exam (3.75-hours) within 30 days of the live webcast session. The AOAAM cannot verify completion of the webinar session if less than 4.25 hours are attended. Should you not attend for the entire session, you will have to retake the entire webinar again on a different date in order to get credit. Please be aware that it is MANDATORY that you are able to view and hear the presentation and participate in the interactive polling questions in order for the AOAAM to verify your attendance. The combined live webcast and online self-study training will provide the required 8 hours needed to obtain the waiver to prescribe buprenorphine in office-based treatment of opioid dependence. Physicians who complete this course will meet the training qualification under the new law. For NPs and PAs, an additional 16-hours of training will be required for waiver eligibility.

CONTINUING MEDICAL EDUCATION: This program has been approved for 4.25 AOA Category 1-A CME credits (live webcast session only) providing all requirements have been met. It has also been approved for 4.25 AAFP Prescribed Credit hours, which are eligible for the AMA’s Physician Recognition Award Credit. Participants are required to attend the entire 4.25-hour session, participate in the interactive polling questions and complete the post-test with a passing grade of 70% in order to be eligible for CME credit. CME certificates will become available once all components of the training are fulfilled.

For More Information and FREE training and educational resources on Medication Assisted Treatment –Providers’ Clinical Support System for Medication Assisted Treatment (PCSS-MAT) visit www.pcssnow.org.

PCSS is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in partnership with the: American Osteopathic Academy of Addiction Medicine (AOAAM); Addiction Technology Transfer Center (ATTC); American Academy of Family Physicians (AAFP); American Academy of Neurology (AAN); American Academy of Pain Medicine (AAPM); American Academy of Pediatrics (AAP); American College of Emergency Physicians (ACEP); American College of Physicians (ACP); American Dental Association (ADA); American Medical Association (AMA); American Psychiatric Association (APA); American Psychiatric Nurses Association (APNA); American Society of Addiction Medicine (ASAM); American Society for Pain Management Nursing (ASPMN); Association for Medical Education and Research in Substance Abuse (AMERSA); International Nurses Society on Addictions (IntNSA); National Association of Community Health Centers (NACHC); National Association of Drug Court Professionals (NADCP), and the Southeast Consortium for Substance Abuse Training (SECSAT). 

Funding for this initiative was made possible (in part) by grant nos. 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.